logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (vi) New inpatient clients, primary drug distribution by age (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids4.022.536.950.454.053.851.533.838621
Cocaine0.02.26.29.510.313.211.76.17240
Stimulants12.018.019.714.410.98.27.911.412976
Hypnotics and sedatives0.00.82.52.63.35.57.925.04151
Hallucinogens0.00.51.10.91.00.90.80.6810
Volatile substances28.010.01.91.41.01.11.00.32341
Cannabis 42.039.126.315.816.213.314.710.118790
Other substances 14.06.95.45.03.23.94.412.64971
Total501187216521391453849495651898910
 

Notes:

The countries supplying data are:

AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Monday, 09 July 2012